Dr. Julie Locklear joins Genesis Research as Managing Partner

Spread the Word
Listed Under

* Health Economics
* Outcomes Research
* Biopharmaceutical

* Biotech

* Hoboken - New Jersey - US

HOBOKEN, N.J. - Jan. 16, 2018 - PRLog -- Genesis Research, a global Life Sciences research and consulting company, announced the appointment of Julie Locklear, PharmD, MBA to Managing Partner, Health Economics and Outcomes Research. Based in Boston, Dr. Locklear will direct and manage a team of scientists, biostatisticians, and programmers to implement strategic client initiatives in Health Economics & Outcomes Research, including data analytics, health economic modeling, simulation, and scientific communications; Market Access solutions and deliverables; Business Development evaluations; Regulatory support and C-suite strategic and innovative solutions.

"Genesis Research is accelerating growth into 2018 through a unique value proposition and service offering," said Dr. Steve Arikian, founder and Managing Director. "Julie will help to further differentiate our services, solutions, and platforms through her deep industry experience across product life cycles and innovative product solutions in many disease areas, including oncology, immunology, immuno-oncology, neurology, pain management and other rare hard-to-treat specialty disease areas."

Dr. Locklear added, "I am very excited to join the Genesis Research organization. This opportunity will enable me to bring my years of industry experience across multiple therapeutic areas along all phases of drug development both globally and locally in the US to facilitate and oversee comprehensive services to our clients in the pharmaceutical and biotech industries. My industry experience will further enable Genesis Research to provide the exact services and solutions our clients need during this rapidly changing healthcare and industry environment."

Dr. Locklear brings over 20 years of strategic health outcomes support and evidence development experience to Genesis Research.

Prior to joining Genesis Research, Dr. Locklear was Vice President and Head of Health Economics and Outcomes Research at EMD Serono, the biopharmaceutical division of Merck KGaA Darmstadt, Germany, where she was responsible for establishing and building the US Health Economics & Outcomes Research team within the Medical Affairs organization. During her tenure, her team of in-house and field-based HEOR professionals developed and disseminated value evidence across a portfolio of key specialty products in the areas of neuroscience, infertility, endocrinology, immunology, oncology and immuno-oncology.

Dr. Locklear previously served as Global Payer Evidence Director at AstraZeneca, where she supported multiple therapeutic areas and functional groups as a member of the core strategic Global Product Team, and as an Associate Director of US Health Economics and Outcomes Research at Janssen Pharmaceutica, where she was responsible for HEOR development activities and customer face to face communication of healthcare economic information.

About Genesis Research

Genesis Research is a global Life Sciences research and consulting company dedicated to providing End-to-End Evidence Development, Management, and Communication services. The company emphasizes strategic client engagement through unique services, solutions, and platforms. Genesis Research is headquartered in Hoboken, NJ. To learn more, visit the company website at http://www.genesisrg.com or contact info@GenesisRG.com.

Media Contact
Michael Livingstone
Director of Operations
(888) 503-2680
Email:***@genesisrg.com Email Verified
Tags:Health Economics, Outcomes Research, Biopharmaceutical
Location:Hoboken - New Jersey - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse

Like PRLog?
Click to Share